Vitamin D pathway activation selectively deactivates signal transducer and activator of transcription (STAT) proteins and inflammatory cytokine production in natural killer leukemic large granular lymphocytes
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute of the National Institutes of Health (R01CA098472, R01CA178393, P30-CA044579-23)
- Bess Family Charitable Fund
- LGL Leukemia Foundation
- Immunology Training Grant (T32AI007496)
- UVA Wagner Fellowship
This publication has 56 references indexed in Scilit:
- FMS-related tyrosine kinase 3 ligand (Flt3L)/CD135 axis in rheumatoid arthritisArthritis Research & Therapy, 2013
- Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activationBlood Cancer Journal, 2013
- Discovery of somatic STAT5b mutations in large granular lymphocytic leukemiaBlood, 2013
- The Implication of Vitamin D and Autoimmunity: a Comprehensive ReviewClinical Reviews in Allergy & Immunology, 2013
- STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemiaBlood, 2012
- How I treat LGL leukemiaBlood, 2011
- The Fms‐like tyrosine kinase 3 ligand, a mediator of B cell survival, is also a marker of lymphoma in primary Sjögren's syndromeArthritis & Rheumatism, 2010
- The role of FLT3 in haematopoietic malignanciesNature Reviews Cancer, 2003
- Overproduction of IFN‐γ and TNF‐α from Natural Killer (NK) Cells Is Associated with Abnormal NK Reactivity and Cognitive Derangement in Alzheimer's DiseaseAnnals of the New York Academy of Sciences, 2000
- The 1,25-dihydroxyvitamin D3 (VD) analogues MC903, EB1089 and KH1060 activate the VD receptor: Homodimers show higher ligand sensitivity than heterodimers with retinoid X receptorsThe Journal of Steroid Biochemistry and Molecular Biology, 1994